Integra Lifesciences Holdings (IART) Other Working Capital Changes (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Other Working Capital Changes of -$762000.0 for Q2 2026, down 20.95% sequentially from -$630000.0 in Q1 2026, and down 165.92% YoY from $1.2 million in Q2 2025.
Integra Lifesciences Holdings (IART) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Other Working Capital Changes for 16 years, with the latest figure at -$762000.0 in Q2 2026.
- Quarterly Other Working Capital Changes fell 165.92% year-over-year to -$762000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$21.1 million (down 274.21% YoY) and the FY2025 annual result came in at -$17.2 million, down 584.63% from the prior year.
- Other Working Capital Changes fell to -$762000.0 in Q2 2026 per IART's latest filing, from -$630000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $21.9 million in Q1 2026 and troughed at -$26.2 million in Q4 2024.
- A 5-year average of $1.9 million and a median of $4.1 million in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 7031.82% in 2024, then tumbled 1349.13% in 2025.
- Over 5 years, Other Working Capital Changes stood at $9.8 million in 2022, then plunged by 95.1% to $483000.0 in 2023, then jumped by 255.69% to $1.7 million in 2024, then sank by 1349.13% to -$21.5 million in 2025, then soared by 96.45% to -$762000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$762000.0, -$630000.0, and -$21.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.44 Mn |
| Jun 30, 2026 | 7.44 Mn |
| Jun 30, 2026 | 7.44 Mn |
| Mar 31, 2026 | 21.88 Mn |
| Mar 31, 2026 | 21.88 Mn |
| Mar 31, 2026 | 21.88 Mn |
| Dec 31, 2025 | -8.34 Mn |
| Dec 31, 2025 | -8.34 Mn |
| Dec 31, 2025 | -8.34 Mn |
| Sep 30, 2025 | -16.22 Mn |
| Sep 30, 2025 | -16.22 Mn |
| Sep 30, 2025 | -16.22 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Mar 31, 2025 | 17.55 Mn |
| Mar 31, 2025 | 17.55 Mn |
| Mar 31, 2025 | 17.55 Mn |
| Dec 31, 2024 | -26.21 Mn |
| Dec 31, 2024 | -26.21 Mn |